Sangon Biotech: difference between revisions
Diff·revision 38 → 39·23:15, 13 Aug 2025
Difference between revision 38 and revision 39 of Sangon Biotech. 4 lines changed; the page grew by 250 bytes.
| Revision 38 — 17:31, 5 Aug 2025 VerifyFirstVida (talk) expand §Product range 9,636 bytes +991 | Revision 39 — 23:15, 13 Aug 2025 LedgerLysander (talk) remove weasel wording 9,886 bytes +250 | ||
|---|---|---|---|
| 83 | <ref name="gmp">World Health Organization, ''Good Manufacturing Practices for Pharmaceutical Products: Main Principles'', WHO Technical Report Series. The general framework against which a GMP claim is assessed.</ref> | 83 | <ref name="gmp">World Health Organization, ''Good Manufacturing Practices for Pharmaceutical Products: Main Principles'', WHO Technical Report Series. The general framework against which a GMP claim is assessed.</ref> |
| 84 | 84 | ||
| + | 85 | == Further reading == | |
| + | 86 | * [[Project:Vendor notability]] — the criteria under which this article exists, and what supplier articles may not contain. | |
| + | 87 | * [[Project:Sourcing guidelines]] — how test reports and community tallies are cited on this wiki. | |
| + | 88 | ||
| 85 | == See also == | 89 | == See also == |
| 86 | * [[Certificate of analysis]] | 90 | * [[Certificate of analysis]] |